Follow the people · Insider
Whittemore Tingley
Whittemore Tingley files insider transactions with the SEC as a chief medical officer of Tenaya Therapeutics (TNYA). We hold 3 disclosed purchases and sales filed since 17 February 2022, 1 of them in the last 90 days.
- Files forTNYA
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 February 2022 — 17 August 2026Chief Medical Officer · Tenaya Therapeutics (TNYA)44 Form 4 lines · source: SEC Form 4
Everything they disclosed
44 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,637 shares of Tenaya TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 1,637 shares of Tenaya TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 1,871 shares of Tenaya TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 2,279 shares of Tenaya TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 3,121 shares of Tenaya TherapeuticsSEC Form 419 May 2026Common Stock · traded 18 May 2026 · filed 19 May 2026
- ▼ sold on the open market 1,642 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 1,642 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 1,876 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 1,642 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 1,642 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 1,876 shares of Tenaya TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- was granted 48,750 shares of Tenaya TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- was granted 318,500 shares of Tenaya Therapeutics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to buy) · traded 3 February 2026 · filed 5 February 2026
- was granted 318,500 shares of Tenaya Therapeutics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to buy) · traded 3 February 2026 · filed 5 February 2026
- was granted 48,750 shares of Tenaya TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 2,877 shares of Tenaya TherapeuticsSEC Form 417 November 2025Common Stock · traded 17 November 2025 · filed 17 November 2025
- ▼ sold on the open market 1,608 shares of Tenaya TherapeuticsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 1,608 shares of Tenaya TherapeuticsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 1,837 shares of Tenaya TherapeuticsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 2,937 shares of Tenaya TherapeuticsSEC Form 416 May 2025Common Stock · traded 16 May 2025 · filed 16 May 2025
- ▼ sold on the open market 1,727 shares of Tenaya TherapeuticsSEC Form 410 March 2025Common Stock · traded 10 March 2025 · filed 10 March 2025
- ▼ sold on the open market 4,073 shares of Tenaya TherapeuticsSEC Form 410 March 2025Common Stock · traded 10 March 2025 · filed 10 March 2025
- ▼ sold on the open market 1,598 shares of Tenaya TherapeuticsSEC Form 410 March 2025Common Stock · traded 10 March 2025 · filed 10 March 2025
- was granted 235,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to buy) · traded 24 January 2025 · filed 28 January 2025
- returned to the issuer 69,982 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- was granted 69,982 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- returned to the issuer 141,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- was granted 141,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- returned to the issuer 205,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- was granted 205,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- returned to the issuer 215,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- was granted 215,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 428 January 2025Stock Option (Right to Buy) · traded 24 January 2025 · filed 28 January 2025
- was granted 40,000 shares of Tenaya TherapeuticsSEC Form 428 January 2025Common Stock · traded 24 January 2025 · filed 28 January 2025
- was granted 31,676 shares of Tenaya TherapeuticsSEC Form 428 January 2025Common Stock · traded 24 January 2025 · filed 28 January 2025
- ▼ sold on the open market 5,803 shares of Tenaya TherapeuticsSEC Form 416 August 2024Common Stock · traded 16 August 2024 · filed 16 August 2024
- ▼ sold on the open market 1,625 shares of Tenaya TherapeuticsSEC Form 416 August 2024Common Stock · traded 16 August 2024 · filed 16 August 2024
- was granted 215,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 427 February 2024Stock Option (Right to buy) · traded 23 February 2024 · filed 27 February 2024
- was granted 35,000 shares of Tenaya TherapeuticsSEC Form 427 February 2024Common Stock · traded 23 February 2024 · filed 27 February 2024
- ▼ sold on the open market 6,500 shares of Tenaya TherapeuticsSEC Form 416 February 2024Common Stock · traded 16 February 2024 · filed 16 February 2024
- ▼ sold on the open market 5,563 shares of Tenaya TherapeuticsSEC Form 418 August 2023Common Stock · traded 16 August 2023 · filed 18 August 2023
- was granted 205,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 417 February 2023Stock Option (Right to buy) · traded 15 February 2023 · filed 17 February 2023
- was granted 35,000 shares of Tenaya TherapeuticsSEC Form 417 February 2023Common Stock · traded 15 February 2023 · filed 17 February 2023
- was granted 45,000 shares of Tenaya TherapeuticsSEC Form 417 February 2023Common Stock · traded 15 February 2023 · filed 17 February 2023
- was granted 141,000 shares of Tenaya Therapeutics (a derivative holding)SEC Form 417 February 2022Stock Option (Right to buy) · traded 15 February 2022 · filed 17 February 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.